Exact Mass: 518.3693

Exact Mass Matches: 518.3693

Found 121 metabolites which its exact mass value is equals to given mass value 518.3693, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

DG(8:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

(2S)-1-Hydroxy-3-(octanoyloxy)propan-2-yl (8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C31H50O6 (518.3607)

DG(8:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/8:0/0:0)

(2S)-3-Hydroxy-2-(octanoyloxy)propyl (8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C31H50O6 (518.3607)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)+=O(5)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(8:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

(2R)-2-hydroxy-3-(octanoyloxy)propyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoate

C31H50O6 (518.3607)

DG(8:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/8:0)

(2S)-2-hydroxy-3-(octanoyloxy)propyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoate

C31H50O6 (518.3607)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(8:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

(2S)-1-Hydroxy-3-(octanoyloxy)propan-2-yl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C31H50O6 (518.3607)

DG(8:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/8:0/0:0)

(2S)-3-Hydroxy-2-(octanoyloxy)propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C31H50O6 (518.3607)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)+=O(15)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(8:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

(2R)-2-Hydroxy-3-(octanoyloxy)propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C31H50O6 (518.3607)

DG(8:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/8:0)

(2S)-2-Hydroxy-3-(octanoyloxy)propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C31H50O6 (518.3607)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(8:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

(2S)-1-Hydroxy-3-(octanoyloxy)propan-2-yl (8Z,11Z,14Z,16E,18R)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C31H50O6 (518.3607)

DG(8:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/8:0/0:0)

(2S)-3-Hydroxy-2-(octanoyloxy)propyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C31H50O6 (518.3607)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(8:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

(2R)-2-Hydroxy-3-(octanoyloxy)propyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C31H50O6 (518.3607)

DG(8:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/8:0)

(2S)-2-Hydroxy-3-(octanoyloxy)propyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C31H50O6 (518.3607)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(8:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

(2S)-1-Hydroxy-3-(octanoyloxy)propan-2-yl (8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C31H50O6 (518.3607)

DG(8:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/8:0/0:0)

(2S)-3-Hydroxy-2-(octanoyloxy)propyl (8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C31H50O6 (518.3607)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(8:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

(2R)-2-Hydroxy-3-(octanoyloxy)propyl (8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C31H50O6 (518.3607)

DG(8:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/8:0)

(2S)-2-Hydroxy-3-(octanoyloxy)propyl (8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C31H50O6 (518.3607)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(8:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

(2S)-1-hydroxy-3-(octanoyloxy)propan-2-yl (5Z,8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoate

C31H50O6 (518.3607)

DG(8:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/8:0/0:0)

(2S)-3-hydroxy-2-(octanoyloxy)propyl (5Z,8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoate

C31H50O6 (518.3607)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(8:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

(2R)-2-Hydroxy-3-(octanoyloxy)propyl (5Z,8Z,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C31H50O6 (518.3607)

DG(8:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/8:0)

(2S)-2-hydroxy-3-(octanoyloxy)propyl (5Z,8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoate

C31H50O6 (518.3607)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(8:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

(2S)-1-Hydroxy-3-(octanoyloxy)propan-2-yl (8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C31H50O6 (518.3607)

DG(8:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/8:0/0:0)

(2S)-3-Hydroxy-2-(octanoyloxy)propyl (8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C31H50O6 (518.3607)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(8:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

(2R)-2-hydroxy-3-(octanoyloxy)propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoate

C31H50O6 (518.3607)

DG(8:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/8:0)

(2S)-2-hydroxy-3-(octanoyloxy)propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoate

C31H50O6 (518.3607)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

Methyl quadrangularate I

(+)-Methyl quadrangularate I

C31H50O6 (518.3607)

3beta,21beta,22beta,24-tetrahydroxy-20alpha-desmethyl-20alpha-methoxycarbonyl-olean-12-ene|kudzusapogenol B|kudzusapogenol B methylester|kuzusapogenol B-methyl ester

C31H50O6 (518.3607)

Methyl 11??-hydroxytormentate

C31H50O6 (518.3607)

C31H50O6

C31H50O6 (518.3607)

Me ester-Belleric acid

C31H50O6 (518.3607)

Me ester-Protobassic acid

C31H50O6 (518.3607)

meliasenin S|methyl (13alpha,14beta,16beta,17alpha,24S)-16,24,25-trihydroxy-3-oxolanost-7-en-21-oate

C31H50O6 (518.3607)

3beta,11alpha,12,15alpha-tetrahydroxyurs-12-en-24-oic acid methyl ester

C31H50O6 (518.3607)

3beta,24-epoxy-2alpha,3alpha,6beta-trihydroxy-D:A-friedooleanan-29-oic acid methyl ester

C31H50O6 (518.3607)

methyl 1alpha,2alpha,3beta,23-tetrahydroxyolean-12-en-28-oate

C31H50O6 (518.3607)

3-O-acetyl-21-O-methyltoosendanpentol

C31H50O6 (518.3607)

Caccigeninmethylester

C31H50O6 (518.3607)

methyl musangicate

C31H50O6 (518.3607)

2alpha,3beta,23-Trihydroxy-11beta-methoxy-urs-12-en-28-oic acid

C31H50O6 (518.3607)

1β-Hydroxyeuscaphic acid

C31H50O6 (518.3607)

(3R,5R,7R,8S,9S,10S,12S,13R,14S,17R)-12-hydroxy-10,13-dimethyl-17-((R)-5-(oxetan-3-yl)pentan-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthrene-3,7-diyl diacetate

"(3R,5R,7R,8S,9S,10S,12S,13R,14S,17R)-12-hydroxy-10,13-dimethyl-17-((R)-5-(oxetan-3-yl)pentan-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthrene-3,7-diyl diacetate"

C31H50O6 (518.3607)

(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-12-hydroxy-10,13-dimethyl-17-((R)-5-(oxetan-3-yl)pentan-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthrene-3,7-diyl diacetate

"(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-12-hydroxy-10,13-dimethyl-17-((R)-5-(oxetan-3-yl)pentan-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthrene-3,7-diyl diacetate"

C31H50O6 (518.3607)

Punicesterone B

20,22alpha-O-isopropylidene-2beta,3beta,14alpha,20R,22R-pentahydroxy-5beta-campest-7-en-6-one

C31H50O6 (518.3607)

Punicesterone C

20,22alpha-O-isopropylidene-2beta,3beta,14alpha,20R,22R-pentahydroxy-5beta-ergost-7-en-6one

C31H50O6 (518.3607)

Chletric acid

3beta,19alpha,23,24-tetrahydroxyurs-12-en-28-oic acid methyl ester

C31H50O6 (518.3607)

DG(8:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

C31H50O6 (518.3607)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/8:0/0:0)

C31H50O6 (518.3607)

DG(8:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

C31H50O6 (518.3607)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/8:0)

C31H50O6 (518.3607)

DG(8:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

C31H50O6 (518.3607)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/8:0/0:0)

C31H50O6 (518.3607)

DG(8:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

C31H50O6 (518.3607)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/8:0)

C31H50O6 (518.3607)

DG(8:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

C31H50O6 (518.3607)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/8:0/0:0)

C31H50O6 (518.3607)

DG(8:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

C31H50O6 (518.3607)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/8:0)

C31H50O6 (518.3607)

DG(8:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

C31H50O6 (518.3607)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/8:0/0:0)

C31H50O6 (518.3607)

DG(8:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

C31H50O6 (518.3607)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/8:0)

C31H50O6 (518.3607)

DG(8:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

C31H50O6 (518.3607)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/8:0/0:0)

C31H50O6 (518.3607)

DG(8:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

C31H50O6 (518.3607)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/8:0)

C31H50O6 (518.3607)

DG(8:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

C31H50O6 (518.3607)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/8:0/0:0)

C31H50O6 (518.3607)

DG(8:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

C31H50O6 (518.3607)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/8:0)

C31H50O6 (518.3607)

(3R,5R,7R,8S,9S,10S,12S,13R,14S,17R)-12-hydroxy-10,13-dimethyl-17-((R)-5-(oxetan-3-yl)pentan-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthrene-3,7-diyl diacetate

C31H50O6 (518.3607)

(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-12-hydroxy-10,13-dimethyl-17-((R)-5-(oxetan-3-yl)pentan-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthrene-3,7-diyl diacetate

C31H50O6 (518.3607)

2-[Carboxy-(2-nonanoyloxy-3-octanoyloxypropoxy)methoxy]ethyl-trimethylazanium

C27H52NO8+ (518.3693)

TG(28:4)

TG(4:0_11:4_13:0)

C31H50O6 (518.3607)

NA-Orn 25:4

C30H50N2O5 (518.372)

ST 25:2;O;Hex

C31H50O6 (518.3607)

10,11-dihydroxy-9-(hydroxymethyl)-13-methoxy-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

C31H50O6 (518.3607)

methyl 1,10,11,13-tetrahydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C31H50O6 (518.3607)

methyl (1r,2r,4as,6as,6br,10s,12ar)-1,10-dihydroxy-9,9-bis(hydroxymethyl)-1,2,6a,6b,12a-pentamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C31H50O6 (518.3607)

methyl (4as,6as,6br,8ar,9r,10r,11r,12s,12ar,12bs,14bs)-10,11,12-trihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C31H50O6 (518.3607)

2α,3β,7β-trihydroxy-11α-methoxyurs-12-en-28-oicacid

C31H50O6 (518.3607)

{"Ingredient_id": "HBIN005219","Ingredient_name": "2\u03b1,3\u03b2,7\u03b2-trihydroxy-11\u03b1-methoxyurs-12-en-28-oicacid","Alias": "NA","Ingredient_formula": "C31H50O6","Ingredient_Smile": "CC1CCC2(CCC3(C(=CC(C4C3(C(CC5C4(CC(C(C5(C)C)O)O)C)O)C)OC)C2C1C)C)C(=O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21773","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

(1's,2s,5s,6r,10'e,12'e,14'r,16'e,19's)-6,6'-diethyl-7'-hydroxy-5,10',14',16'-tetramethylspiro[oxane-2,21'-tricyclo[17.3.1.0⁴,⁹]tricosane]-4'(9'),5',7',10',12',16'-hexaen-3'-one

C35H50O3 (518.376)

methyl 1,10-dihydroxy-9,9-bis(hydroxymethyl)-2,2,6a,6b,12a-pentamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C31H50O6 (518.3607)

(1r,3br,4r,5ar,9ar,9br,11as)-1-[(2r,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

(1r,3br,4r,5ar,9ar,9br,11as)-1-[(2r,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

C31H50O6 (518.3607)

(2r)-2-[(1r,2r,3ar,5ar,7s,9as,11ar)-2,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-5-hydroxy-6-methoxy-6-methylheptanoic acid

C31H50O6 (518.3607)

(1s,3br,4r,5ar,9ar,9br,11as)-1-[(2r,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

(1s,3br,4r,5ar,9ar,9br,11as)-1-[(2r,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

C31H50O6 (518.3607)

methyl (2s,3r,4s,4ar,6as,6br,8ar,9s,10s,12ar,12br,14bs)-3,4,10-trihydroxy-9-(hydroxymethyl)-2,4a,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-2-carboxylate

C31H50O6 (518.3607)

(5r)-5-(5-{[(4as,9s,10as)-6-hydroxy-7-isopropyl-1,1,4a-trimethyl-2,3,4,9,10,10a-hexahydrophenanthren-9-yl]methyl}-2-hydroxyphenyl)-6-methylheptan-2-one

C35H50O3 (518.376)

methyl 1,4,10,11-tetrahydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C31H50O6 (518.3607)

methyl (1r,2r,4as,6as,6br,8ar,9s,10s,11r,12ar,12br,14bs)-1,10,11-trihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C31H50O6 (518.3607)

methyl (1s,4ar,6as,6br,10s,12ar)-1,10-dihydroxy-9,9-bis(hydroxymethyl)-2,2,6a,6b,12a-pentamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C31H50O6 (518.3607)

methyl (1r,2r,4as,6as,6br,8ar,9r,10s,11r,12ar,12br,14bs)-1,10,11-trihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C31H50O6 (518.3607)

methyl (1r,2r,4s,4as,6as,6br,8ar,10s,11r,12ar,12br,14bs)-1,4,10,11-tetrahydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C31H50O6 (518.3607)

methyl (1r,2r,4as,6as,6br,8ar,9s,10r,11r,12ar,12br,14bs)-1,10,11-trihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C31H50O6 (518.3607)

methyl 1,10,11-trihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C31H50O6 (518.3607)

(5s)-5-(5-{[(4as,9s,10as)-6-hydroxy-7-isopropyl-1,1,4a-trimethyl-2,3,4,9,10,10a-hexahydrophenanthren-9-yl]methyl}-2-hydroxyphenyl)-6-methylheptan-2-one

C35H50O3 (518.376)

(1r,2s,3s)-1-[(1r,2s,3's,3as,3br,5as,9as,9bs,11as)-2-hydroxy-3',9a,11a-trimethyl-7-oxo-dodecahydro-2h-spiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl]-4-hydroxy-2,3,4-trimethylpentyl acetate

C31H50O6 (518.3607)

methyl (1s,2r,4as,6as,6br,8ar,9r,10r,11r,12s,12ar,12bs,14bs)-10,11,12-trihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylate

methyl (1s,2r,4as,6as,6br,8ar,9r,10r,11r,12s,12ar,12bs,14bs)-10,11,12-trihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylate

C31H50O6 (518.3607)

methyl (1s,3s,4s,6s,7s,8r,11s,12s,15r,16r)-15-[(2r,5s)-1,5-dihydroxy-6-methylhept-6-en-2-yl]-4,6-dihydroxy-7,12,16-trimethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecane-7-carboxylate

C31H50O6 (518.3607)

methyl (1r,2r,4as,6as,6br,8ar,10r,11r,12as,12br,13r,14bs)-1,10,11,13-tetrahydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C31H50O6 (518.3607)

1-(5-ethyl-7-hydroxyheptan-2-yl)-3,10-dihydroxy-9a,11a-dimethyl-4-oxo-1h,2h,3h,3ah,3bh,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl propanoate

C31H50O6 (518.3607)

4-hydroxy-1-{2-hydroxy-3',9a,11a-trimethyl-7-oxo-dodecahydro-2h-spiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl}-2,3,4-trimethylpentyl acetate

C31H50O6 (518.3607)

(1s,2r,4as,6ar,6br,7s,8as,10r,11r,12as,12bs,13r,14bs)-7,10,11-trihydroxy-13-methoxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

C31H50O6 (518.3607)

(1s,2r,4as,6as,6br,8ar,9r,10r,11r,12as,12br,13r,14br)-10,11-dihydroxy-9-(hydroxymethyl)-13-methoxy-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

(1s,2r,4as,6as,6br,8ar,9r,10r,11r,12as,12br,13r,14br)-10,11-dihydroxy-9-(hydroxymethyl)-13-methoxy-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

C31H50O6 (518.3607)

methyl 3,4,10-trihydroxy-9-(hydroxymethyl)-2,4a,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-2-carboxylate

C31H50O6 (518.3607)

(1r,3ar,5s,5as,6r,7s,9ar,9br,11ar)-6-(acetyloxy)-7-hydroxy-1-[(2s,3r)-3-hydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-yl acetate

C31H50O6 (518.3607)

(1r,3r,3as,3bs,7s,9ar,9bs,10r,11ar)-3,10-dihydroxy-1-[(2r,5r)-7-hydroxy-5-isopropylheptan-2-yl]-9a,11a-dimethyl-4-oxo-1h,2h,3h,3ah,3bh,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C31H50O6 (518.3607)

1-[5-(1,2-dihydroxy-2-methylpropyl)-2-methoxyoxolan-3-yl]-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

C31H50O6 (518.3607)

5-{2-hydroxy-5-[(6-hydroxy-7-isopropyl-1,1,4a-trimethyl-2,3,4,9,10,10a-hexahydrophenanthren-9-yl)methyl]phenyl}-6-methylheptan-2-one

C35H50O3 (518.376)

7,10,11-trihydroxy-13-methoxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

C31H50O6 (518.3607)

(1r,3r,3as,3bs,7s,9ar,9br,10r,11ar)-1-[(2r,5r)-5-ethyl-7-hydroxyheptan-2-yl]-3,10-dihydroxy-9a,11a-dimethyl-4-oxo-1h,2h,3h,3ah,3bh,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl propanoate

C31H50O6 (518.3607)

methyl 1,10-dihydroxy-9,9-bis(hydroxymethyl)-1,2,6a,6b,12a-pentamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C31H50O6 (518.3607)

(1s,2r,4as,6ar,6br,7s,8ar,10r,11r,12as,12br,13r,14bs)-7,10,11-trihydroxy-13-methoxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

C31H50O6 (518.3607)